These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 33590574)

  • 1. Monitoring institutions in healthcare markets: Experimental evidence.
    Angerer S; Glätzle-Rützler D; Waibel C
    Health Econ; 2021 May; 30(5):951-971. PubMed ID: 33590574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separation of prescription and treatment in health care markets: A laboratory experiment.
    Greiner B; Zhang L; Tang C
    Health Econ; 2017 Dec; 26 Suppl 3():21-35. PubMed ID: 29285866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insurance coverage of customers induces dishonesty of sellers in markets for credence goods.
    Kerschbamer R; Neururer D; Sutter M
    Proc Natl Acad Sci U S A; 2016 Jul; 113(27):7454-8. PubMed ID: 27325784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How does market competition affect supplier-induced demand? An experimental study.
    Chen Y; Pan Y; Ding Y
    Front Public Health; 2023; 11():1024337. PubMed ID: 36969642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Physician Supply on the Healthcare System: Evidence from Japan's New Residency Program.
    Iizuka T; Watanabe Y
    Health Econ; 2016 Nov; 25(11):1433-1447. PubMed ID: 26337682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing the health care market in developing countries: prospects and problems.
    Broomberg J
    Health Policy Plan; 1994 Sep; 9(3):237-51. PubMed ID: 10137740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients' free choice of physicians is not always good.
    Li X; Waibel C
    Health Econ; 2021 Nov; 30(11):2751-2765. PubMed ID: 34387018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Containing costs in the Italian local healthcare market.
    Riganti A
    Health Econ; 2021 May; 30(5):1001-1014. PubMed ID: 33638596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Market reforms and public incentives: finding a balance in the Republic of Macedonia.
    Nordyke RJ; Peabody JW
    Soc Sci Med; 2002 Mar; 54(6):939-53. PubMed ID: 11996027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory theory: commercially sustainable markets rely upon satisfying the public interest in obtaining credible goods.
    Warren-Jones A
    Health Econ Policy Law; 2017 Oct; 12(4):471-493. PubMed ID: 28414003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Making Markets in Long-Term Care: Or How a Market Can Work by Being Invisible.
    Grit K; Zuiderent-Jerak T
    Health Care Anal; 2017 Sep; 25(3):242-259. PubMed ID: 25953060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innovation in regulation of rapidly changing health markets.
    Bloom G; Henson S; Peters DH
    Global Health; 2014 Jun; 10():53. PubMed ID: 24961602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ends versus means: the role of markets in expanding access to contraceptives.
    Hanson K; Kumaranayake L; Thomas I
    Health Policy Plan; 2001 Jun; 16(2):125-36. PubMed ID: 11358913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of priming on fraud: Evidence from a natural field experiment.
    Bindra PC; Pearce G
    Econ Inq; 2022 Oct; 60(4):1854-1874. PubMed ID: 36247654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health Care Market Concentration Trends In The United States: Evidence And Policy Responses.
    Fulton BD
    Health Aff (Millwood); 2017 Sep; 36(9):1530-1538. PubMed ID: 28874478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valuing charity.
    Kronick R
    J Health Polit Policy Law; 2001 Oct; 26(5):993-1001. PubMed ID: 11765276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Cross-Sectional Study of Overtreatment and Deintensification of Antidiabetic and Antihypertensive Medications in Diabetes Mellitus: The TEMD Overtreatment Study.
    Sonmez A; Tasci I; Demirci I; Haymana C; Barcin C; Aydin H; Cetinkalp S; Ozturk FY; Gul K; Sabuncu T; Satman I; Bayram F;
    Diabetes Ther; 2020 May; 11(5):1045-1059. PubMed ID: 32088879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Maine's Medicaid drug formulary change on non-Medicaid markets: spillover effects of a restrictive drug formulary.
    Wang YR; Pauly MV; Lin YA
    Am J Manag Care; 2003 Oct; 9(10):686-96. PubMed ID: 14572179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public-private partnerships in healthcare: the managers' perspective.
    Field JE; Peck E
    Health Soc Care Community; 2003 Nov; 11(6):494-501. PubMed ID: 14629580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The multi-tiered medical education system and its influence on the health care market-China's Flexner Report.
    Hsieh CR; Tang C
    Hum Resour Health; 2019 Jul; 17(1):50. PubMed ID: 31277652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.